Real-World Effectiveness, Safety and Tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/Taf) In Routine Clinical Practice in People Living With HIV (Plwh), China

APACC 2021

Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/Taf) In Treatment Experienced Patients – Asian Real-World Experience

APACC 2021

Cost-Effectiveness of Dtg/3tc for Human Immunodeficiency Virus (HIV-1) Infection Treatment in Taiwan

APACC 2021

Efficacy, Safety and Tolerability of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/Taf) Among People Living With HIV in a Real-World Setting

APACC 2021

Durable Efficacy of Dolutegravir (Dtg) Plus Lamivudine (3tc) In Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 3-Year Results From the Gemini Studies in Participants From Asian Centers

APACC 2021